These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


337 related items for PubMed ID: 9614189

  • 1. The endogenous and cell cycle-dependent phosphorylation of tau protein in living cells: implications for Alzheimer's disease.
    Illenberger S, Zheng-Fischhöfer Q, Preuss U, Stamer K, Baumann K, Trinczek B, Biernat J, Godemann R, Mandelkow EM, Mandelkow E.
    Mol Biol Cell; 1998 Jun; 9(6):1495-512. PubMed ID: 9614189
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Phosphorylation of tau at both Thr 231 and Ser 262 is required for maximal inhibition of its binding to microtubules.
    Sengupta A, Kabat J, Novak M, Wu Q, Grundke-Iqbal I, Iqbal K.
    Arch Biochem Biophys; 1998 Sep 15; 357(2):299-309. PubMed ID: 9735171
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells.
    Lovestone S, Reynolds CH, Latimer D, Davis DR, Anderton BH, Gallo JM, Hanger D, Mulot S, Marquardt B, Stabel S.
    Curr Biol; 1994 Dec 01; 4(12):1077-86. PubMed ID: 7704571
    [Abstract] [Full Text] [Related]

  • 6. Alzheimer-like changes in microtubule-associated protein Tau induced by sulfated glycosaminoglycans. Inhibition of microtubule binding, stimulation of phosphorylation, and filament assembly depend on the degree of sulfation.
    Hasegawa M, Crowther RA, Jakes R, Goedert M.
    J Biol Chem; 1997 Dec 26; 272(52):33118-24. PubMed ID: 9407097
    [Abstract] [Full Text] [Related]

  • 7. Phosphorylation of tau by glycogen synthase kinase-3 beta in intact mammalian cells: the effects on the organization and stability of microtubules.
    Lovestone S, Hartley CL, Pearce J, Anderton BH.
    Neuroscience; 1996 Aug 26; 73(4):1145-57. PubMed ID: 8809831
    [Abstract] [Full Text] [Related]

  • 8. Mitotic phosphorylation of tau protein in neuronal cell lines resembles phosphorylation in Alzheimer's disease.
    Preuss U, Mandelkow EM.
    Eur J Cell Biol; 1998 Jul 26; 76(3):176-84. PubMed ID: 9716264
    [Abstract] [Full Text] [Related]

  • 9. Glycogen synthase kinase-3 beta phosphorylates tau protein at multiple sites in intact cells.
    Sperber BR, Leight S, Goedert M, Lee VM.
    Neurosci Lett; 1995 Sep 08; 197(2):149-53. PubMed ID: 8552282
    [Abstract] [Full Text] [Related]

  • 10. Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments.
    Schneider A, Biernat J, von Bergen M, Mandelkow E, Mandelkow EM.
    Biochemistry; 1999 Mar 23; 38(12):3549-58. PubMed ID: 10090741
    [Abstract] [Full Text] [Related]

  • 11. Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors?
    Leclerc S, Garnier M, Hoessel R, Marko D, Bibb JA, Snyder GL, Greengard P, Biernat J, Wu YZ, Mandelkow EM, Eisenbrand G, Meijer L.
    J Biol Chem; 2001 Jan 05; 276(1):251-60. PubMed ID: 11013232
    [Abstract] [Full Text] [Related]

  • 12. Phosphorylation of human tau protein by microtubule-associated kinases: GSK3beta and cdk5 are key participants.
    Flaherty DB, Soria JP, Tomasiewicz HG, Wood JG.
    J Neurosci Res; 2000 Nov 01; 62(3):463-72. PubMed ID: 11054815
    [Abstract] [Full Text] [Related]

  • 13. Neurofibrillary tangles and tau phosphorylation.
    Brion JP, Anderton BH, Authelet M, Dayanandan R, Leroy K, Lovestone S, Octave JN, Pradier L, Touchet N, Tremp G.
    Biochem Soc Symp; 2001 Nov 01; (67):81-8. PubMed ID: 11447842
    [Abstract] [Full Text] [Related]

  • 14. Role of protein phosphatase-2A and -1 in the regulation of GSK-3, cdk5 and cdc2 and the phosphorylation of tau in rat forebrain.
    Bennecib M, Gong CX, Grundke-Iqbal I, Iqbal K.
    FEBS Lett; 2000 Nov 17; 485(1):87-93. PubMed ID: 11086171
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of protein phosphatase 2A overrides tau protein kinase I/glycogen synthase kinase 3 beta and cyclin-dependent kinase 5 inhibition and results in tau hyperphosphorylation in the hippocampus of starved mouse.
    Planel E, Yasutake K, Fujita SC, Ishiguro K.
    J Biol Chem; 2001 Sep 07; 276(36):34298-306. PubMed ID: 11441005
    [Abstract] [Full Text] [Related]

  • 16. Brain proline-directed protein kinase phosphorylates tau on sites that are abnormally phosphorylated in tau associated with Alzheimer's paired helical filaments.
    Paudel HK, Lew J, Ali Z, Wang JH.
    J Biol Chem; 1993 Nov 05; 268(31):23512-8. PubMed ID: 8226879
    [Abstract] [Full Text] [Related]

  • 17. Tyrosine 394 is phosphorylated in Alzheimer's paired helical filament tau and in fetal tau with c-Abl as the candidate tyrosine kinase.
    Derkinderen P, Scales TM, Hanger DP, Leung KY, Byers HL, Ward MA, Lenz C, Price C, Bird IN, Perera T, Kellie S, Williamson R, Noble W, Van Etten RA, Leroy K, Brion JP, Reynolds CH, Anderton BH.
    J Neurosci; 2005 Jul 13; 25(28):6584-93. PubMed ID: 16014719
    [Abstract] [Full Text] [Related]

  • 18. Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry: differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and P38, and glycogen synthase kinase-3beta.
    Reynolds CH, Betts JC, Blackstock WP, Nebreda AR, Anderton BH.
    J Neurochem; 2000 Apr 13; 74(4):1587-95. PubMed ID: 10737616
    [Abstract] [Full Text] [Related]

  • 19. Abnormal Alzheimer-like phosphorylation of tau-protein by cyclin-dependent kinases cdk2 and cdk5.
    Baumann K, Mandelkow EM, Biernat J, Piwnica-Worms H, Mandelkow E.
    FEBS Lett; 1993 Dec 28; 336(3):417-24. PubMed ID: 8282104
    [Abstract] [Full Text] [Related]

  • 20. Dephosphorylation of abnormal sites of tau factor by protein phosphatases and its implication for Alzheimer's disease.
    Ono T, Yamamoto H, Tashima K, Nakashima H, Okumura E, Yamada K, Hisanaga S, Kishimoto T, Miyakawa T, Miyamoto E.
    Neurochem Int; 1995 Mar 28; 26(3):205-15. PubMed ID: 7787767
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.